Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Evoke Pharma (EVOK)

2.71   -0.05 (-1.81%) 01-27 03:13
Open: 2.81 Pre. Close: 2.76
High: 2.81 Low: 2.7
Volume: 313,108 Market Cap: 85M
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. The company is headquartered in Solana Beach, California and currently employs 6 full-time employees. The firm is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The firm is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. EVK-001 is a formulation of Metoclopramide drug, designed to provide systemic delivery of metoclopramide through intranasal administration. The firm has evaluated EVK-001 in a multicenter, randomized, double-blind, placebo-controlled parallel group, dose-ranging Phase IIb clinical trial. The firm has commenced a Phase III clinical trial of EVK-001 in female patients with symptoms associated with acute and recurrent diabetic gastroparesis. The Phase III clinical trial is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety and population pharmacokinetics of EVK-001 in adult females.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.813 - 2.836 2.836 - 2.851
Low: 2.653 - 2.678 2.678 - 2.695
Close: 2.678 - 2.716 2.716 - 2.742

Technical analysis

as of: 2021-01-26 4:43:36 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.77     One year: 4.30
Support: Support1: 2.50    Support2: 2.08
Resistance: Resistance1: 3.23    Resistance2: 3.68
Pivot: 2.76
Moving Average: MA(5): 2.81     MA(20): 2.73
MA(100): 3.72     MA(250): 2.93
MACD: MACD(12,26): -0.04     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 20.87     %D(3): 25.78
RSI: RSI(14): 44.80
52-week: High: 6.06  Low: 0.79  Change(%): 80.7
Average Vol(K): 3-Month: 35428  10-Days: 86141

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
EVOK has closed above bottom band by 38.0%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to EVOK's normal range. The bands have been in this narrow range for 33 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 19 Jan 2021
Evoke Pharma (NASDAQ:EVOK) Cut to Hold at Zacks Investment Research - MarketBeat

Sun, 17 Jan 2021
Evoke Pharma - Consensus Indicates Potential 226.5% Upside - DirectorsTalk Interviews

Thu, 14 Jan 2021
What is Wall Street's Target Price for Evoke Pharma Inc (EVOK) Stock? - InvestorsObserver

Thu, 14 Jan 2021
Form 424B5 Evoke Pharma Inc - StreetInsider.com

Thu, 14 Jan 2021
Evoke Pharma slips 7% after pricing equity offering - Seeking Alpha

Wed, 13 Jan 2021
Evoke Pharma Announces Pricing of Public Offering of Common Stock - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 26
Shares Float (M) 23
% Held by Insiders 3.92
% Held by Institutions 14.97
Shares Short (K) 469
Shares Short P. Month (K) 357

Stock Financials

EPS -0.493
EPS Est This Year -0.820
EPS Est Next Year -0.170
Book Value (p.s.) -0.070
Profit Margin
Operating Margin
Return on Assets (ttm) -108.9
Return on Equity (ttm) -757.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) -2

Stock Valuations

PE Ratio -5.50
PEG Ratio
Price to Book value -38.71
Price to Sales
Price to Cash Flow -11.78

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.